Literature DB >> 9357798

Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance.

B Ahrén1, G Pacini.   

Abstract

This study examined whether insulin secretion, insulin sensitivity, glucose effectiveness, and hepatic extraction of insulin are altered in subjects with impaired glucose tolerance (IGT). The frequently sampled intravenous glucose tolerance test was performed in postmenopausal women (age 63 yr, body mass index range 21.6-28.9 kg/m2) with IGT (n = 10) or normal glucose tolerance (NGT; n = 10). Insulin sensitivity (S(I)) was significantly lower in IGT than in NGT (P = 0.030). In contrast, insulin secretion was not significantly different between the two groups as determined by area under the curve for insulin and C-peptide, acute insulin response to glucose (AIR(G)), and glucose sensitivity of first-phase (phi1) or of second-phase (phi2) insulin secretion. In NGT (r = -0.68, P = 0.029) but not in IGT (r = -0.05, not significant), S(I) correlated negatively with phi1. The B-cell "adaptation index" (S(I) x phi1) was lower in IGT than in NGT [83 +/- 25 vs. 171 +/- 29 min(-2)/(mmol/l), P = 0.042]. Also, the B-cell "disposition index" (S(I) times AIR(G)) was lower in IGT (83 +/- 25 10(-4) min(-1)) than in NGT (196 +/- 30 10(-4) min(-1), p = 0.011). In contrast, glucose effectiveness or hepatic extraction of insulin was not different between IGT and NGT. We conclude that postmenopausal women with IGT fail to adequately adapt to lowered S(I) by increasing first-phase insulin secretion.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357798     DOI: 10.1152/ajpendo.1997.273.4.E701

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

1.  Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

Authors:  K Faerch; K Borch-Johnsen; J J Holst; A Vaag
Journal:  Diabetologia       Date:  2009-07-10       Impact factor: 10.122

2.  The rs10830963 Polymorphism of the MTNR1B Gene: Association With Abnormal Glucose, Insulin and C-peptide Kinetics.

Authors:  Daniela Vejrazkova; Marketa Vankova; Josef Vcelak; Hana Krejci; Katerina Anderlova; Andrea Tura; Giovanni Pacini; Alena Sumova; Martin Sladek; Bela Bendlova
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-06       Impact factor: 6.055

3.  Consequences on islet and incretin hormone responses to dinner by omission of lunch in healthy men.

Authors:  Ola Lindgren; Bo Ahrén
Journal:  Endocrinol Diabetes Metab       Date:  2020-04-28

4.  Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.

Authors:  A Gastaldelli; E Ferrannini; Y Miyazaki; M Matsuda; R A DeFronzo
Journal:  Diabetologia       Date:  2003-12-10       Impact factor: 10.122

5.  Evidence that autonomic mechanisms contribute to the adaptive increase in insulin secretion during dexamethasone-induced insulin resistance in humans.

Authors:  B Ahrén
Journal:  Diabetologia       Date:  2008-04-24       Impact factor: 10.122

6.  A Pathophysiology of Type 2 Diabetes Unrelated to Metabolic Syndrome.

Authors:  Marietta Rottenkolber; Christina Gar; Cornelia Then; Lorena Wanger; Vanessa Sacco; Friederike Banning; Anne L Potzel; Stefanie Kern-Matschilles; Claudia Nevinny-Stickel-Hinzpeter; Harald Grallert; Nina Hesse; Jochen Seissler; Andreas Lechner
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

Review 7.  Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin.

Authors:  Bo Ahrén
Journal:  Vasc Health Risk Manag       Date:  2008

8.  Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance.

Authors:  Sabine Kahl; Klaus Straßburger; Bettina Nowotny; Roshan Livingstone; Birgit Klüppelholz; Kathrin Keßel; Jong-Hee Hwang; Guido Giani; Barbara Hoffmann; Giovanni Pacini; Amalia Gastaldelli; Michael Roden
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

9.  Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.

Authors:  Ammon Handisurya; Corinna Kerscher; Andrea Tura; Harald Herkner; Berit Anna Payer; Mattias Mandorfer; Johannes Werzowa; Wolfgang Winnicki; Thomas Reiberger; Alexandra Kautzky-Willer; Giovanni Pacini; Marcus Säemann; Alice Schmidt
Journal:  PLoS One       Date:  2016-01-06       Impact factor: 3.240

Review 10.  Glucose effectiveness: Lessons from studies on insulin-independent glucose clearance in mice.

Authors:  Bo Ahrén; Giovanni Pacini
Journal:  J Diabetes Investig       Date:  2020-12-01       Impact factor: 4.232

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.